These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5398278)

  • 1. [Plasmatic antithrombin activity in multiple myeloma].
    Nenci GG; Notaristefano A
    Boll Soc Ital Biol Sper; 1969 Nov; 45(22):1389-91. PubMed ID: 5398278
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypercalcemia and antithrombin activity in a case of IgA myeloma].
    Baele G; Lameire N
    Ned Tijdschr Geneeskd; 1972 Aug; 116(33):1444-50. PubMed ID: 5069831
    [No Abstract]   [Full Text] [Related]  

  • 3. Letters to the editor: Antithrombin and antithromboplastin activity accompanying IgG myeloma.
    Hensen A; Loeliger EA
    Am J Clin Pathol; 1975 Dec; 64(6):820-2. PubMed ID: 1202940
    [No Abstract]   [Full Text] [Related]  

  • 4. [Method of determining total antithrombin activity, antithrombins II, 3 and IV].
    Babich VP; Byshevskii ASh
    Lab Delo; 1972; 8():467-70. PubMed ID: 4124339
    [No Abstract]   [Full Text] [Related]  

  • 5. [Application of new methods for studies in the area of blood coagulation. 3. Gel diffusion test for quantitative determination of total antithrombin capacity of plasma].
    Doleschel W
    Wien Med Wochenschr; 1972 Oct; 122(42):601-6. PubMed ID: 4628200
    [No Abstract]   [Full Text] [Related]  

  • 6. [A HEPARIN-TYPE ANTITHROMBIN IN A GAMMA-MYELOMA. CONSIDERATIONS ON SPONTANEOUS ANTICOAGULANTS IN KAHLER'S DISEASE].
    FAVRE-GILLY J; CREYSSEL R; THOUVEREZ JP; REVOL L; CROIZAT P
    Hemostase; 1963; 3():325-33. PubMed ID: 14151020
    [No Abstract]   [Full Text] [Related]  

  • 7. [Circulating heparinoid anticoagulant (antithrombin II). Report of a fatal case and review of the problem].
    Goldstein C; Sumoza A; De Bosch N; De Sanz N
    Sangre (Barc); 1973; 18(3):313-21. PubMed ID: 4757640
    [No Abstract]   [Full Text] [Related]  

  • 8. Periorbital ecchymoses as the initial sign in multiple myeloma.
    Loo H; Forman WB; Levine MR; Crum ED; Rassiga AL
    Ann Ophthalmol; 1982 Nov; 14(11):1066-8. PubMed ID: 7181338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coagulation inhibitory factor: antithrombin--with special reference to antithrombin 3].
    Fujimaki M; Nagasawa H
    Nihon Rinsho; 1974 May; 32(5):942-7. PubMed ID: 4211348
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral contraceptives and low antithrombin-3 activity.
    von Kaulla E; von Kaulla KN
    Lancet; 1970 Jan; 1(7636):36. PubMed ID: 4188357
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombin activity of serum from the native or recalcified blood.
    Gaertner HA; Okulski J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(4):454-8. PubMed ID: 4168281
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes of the blood coagulation system in multiple myeloma].
    Alekseev NA; Klimova KN; Ushakova EA
    Probl Gematol Pereliv Krovi; 1967 Dec; 12(12):24-9. PubMed ID: 5616890
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet function and survival in multiple myeloma.
    Gorski J; Luka K; Czestochowska E
    Haematologia (Budap); 1993; 25(2):131-5. PubMed ID: 8244200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Various aspects of blood coagulation in chronic pancreatitis with special reference to the antithrombin test].
    Facchini G; Fontana G; Cremonini GP; Scarcella D
    G Clin Med; 1969 Jan; 50(1):75-89. PubMed ID: 5386457
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antithrombin V--a rare concomitant symptom in plasmacytoma and autoimmune diseases].
    Lutze G; Dieckmann U; Franke A; Mittler U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):278-92. PubMed ID: 6194061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blood coagulation mechanism in multiple myeloma.
    Zangari M; Saghafifar F; Mehta P; Barlogie B; Fink L; Tricot G
    Semin Thromb Hemost; 2003 Jun; 29(3):275-82. PubMed ID: 12888931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the effect of antithrombin on thrombin clotting and thrombin esterase activity.
    Gans H; Boulton A
    Thromb Diath Haemorrh; 1969 Aug; 22(1):28-31. PubMed ID: 5821245
    [No Abstract]   [Full Text] [Related]  

  • 18. Central retinal vein occlusion in two patients with immunoglobulin G multiple myeloma associated with blood hyperviscosity.
    Hayasaka S; Ugomori S; Kodama T; Noda S; Setogawa T
    Ann Ophthalmol; 1993 May; 25(5):191-4. PubMed ID: 8517591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO discrepancy in a multiple myeloma patient: a case study.
    Wilson JA; Jacobs A
    Clin Lab Sci; 2002; 15(4):204-7. PubMed ID: 12776779
    [No Abstract]   [Full Text] [Related]  

  • 20. On the nature of antithrombin V.
    Vinazzer H; Reinhardt F
    Thromb Diath Haemorrh; 1968 Nov; 20(1):234-46. PubMed ID: 5708894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.